Data Vantage | Temasek’s capital injection into GenZero and other updates
Edition #505, 18th Sept 2025
You’re reading a redacted version of DealStreetAsia’s twice-weekly DATA VANTAGE newsletter. Subscribe to Premium Plus and use code “DVNL10” to get 10% off and unlock full access.
By Corry Anestia and Deandra Syarizka
Dear Reader,
GenZero, a Temasek-founded firm that focuses on decarbonisation investments, has secured another significant capital injection from its parent company, according to its latest filings with Singapore’s Accounting and Corporate Regulatory Authority (ACRA).
The filing, dated September 8, 2025, revealed that the Singapore-based company received a total of [redacted] million in three tranches from Pieter Investments Pte. Ltd, Temasek Holdings’ investment vehicle.
The latest infusion brings Temasek’s total investment in GenZero this year to…
Want the full details? Subscribe to read more.
Capital commitments in SE Asian green tech shrink as deal volume surges
Equity funding in Southeast Asian green tech startups saw a contraction in January-June 2025, even as deal volume picked up compared to the previous semester (H2 2024), finds DealStreetAsia DATA VANTAGE’s Southeast Asia Startup Funding Report: H1 2025.
The data showed that green tech startups raised just $56 million across 20 deals, a sharp drop from H2 2024, when startups in the region amassed $195 million despite only 16 transactions. On a year-on-year basis, H1 2025 deal count also recorded a slight decrease.
The decline further reflects the wide valuation gap across sub-categories…
Want the full details? Subscribe to read more.
The data and information in this newsletter comes from DATA VANTAGE, which tracks regulatory filings to provide you with the latest information on startup fundraising, shareholding and financials. Find out how it can aid you in your decision-making — book a demo today or write to us at subs@dealstreetasia.com
Schedule a free demo session now Executives at top investment firms, financial services majors, and leading private companies use DATA VANTAGE to make smarter investment decisions in Asia. (See how)
Other updates from DATA VANTAGE
Zig Ventures-backed bio-instrumentation company Curiox Biosystems posted a strong financial result for the year ended December 2024, with revenue surging 51% year-on-year to [redacted] million, while the company’s losses significantly narrowed during the period.
[redacted], a digital asset banking group with dual headquarters in Singapore and Switzerland, reported a total revenue of [redacted] million for the fiscal year ended December 2024, marking a 1.6 times YoY growth. The company, which cemented its unicorn status earlier this year, also managed to shrink its losses to $1.85 million.
Singapore-based biotech startup KYAN Therapeutics saw its net losses widen to [redacted] million for the 12-month period ended December 2024, despite…
Want the full details? Subscribe to read more.
SUBSCRIBE This is just a glimpse. The full DATA VANTAGE newsletter delivers deeper intelligence and sharper insights twice a week. Subscribe now with code “DVNL10” on Premium Plus plan to get 10% off and unlock full access. Anticipate Asia’s Rising Stars and Secure Lucrative Exits
To keep pace with today’s constantly evolving markets, data must be smarter, deeper, and instantly accessible. DATA VANTAGE is our smart, continuously updated research & analytics platform featuring:
- Key financials, fundraising data, and shareholding information for over 3,000 Asian venture-backed companies registered in Singapore and Indonesia
- Up to 3 new research reports per month
- Monthly and quarterly data on private funding in SE Asia, India, and Greater China
- Twice-weekly DATA VANTAGE premium newsletter
- Alerts for monitoring companies and sectors
- 50% discount on tickets to our flagship summit
- Full access to DealStreetAsia’s premium stories and archives
Combine editorial insights with robust data & research. Gain a competitive edge in the ever-changing private capital investment landscape.
>> Curious? Book a demo now to explore our database!<< © DEALSTREETASIA 2014–2024.
